Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bioventures, Llc Emerald currently holds 61,029,978 shares of Galera Therapeutics, Inc. (GRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioventures, Llc Emerald has been a net neutral trader of GRTX stock. They have purchased $0 and sold $0 worth of shares.
Bioventures, Llc Emerald's most recent insider trade was on May 15, 2026, when they sold 20,813.82 shares at $0.00 per share.
Bioventures, Llc Emerald serves as Executive at Galera Therapeutics, Inc. (GRTX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Bioventures, Llc Emerald holds the position of Executive at Galera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Bioventures, Llc Emerald has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Bioventures, Llc Emerald was on May 15, 2026, when they sold $0 worth of GRTX shares. This transaction involved 20,813.82 shares at N/A per share.
Bioventures, Llc Emerald currently owns 61,029,978 shares of Galera Therapeutics, Inc. (GRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bioventures, Llc Emerald's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bioventures, Llc Emerald has 2 Form 4 filings on record as an insider at Galera Therapeutics, Inc..
Set alerts for Bioventures, Llc Emerald and 40,000+ other insiders.